ENT Specialist | Subscribe

Nasal Treatment

Immunotherapy As A Form Of Long-Term Nasal Treatment

Unlike non-chronic illnesses, severe allergies can’t be treated by over-the counter medication. Severe nasal allergies require long-term Nasal Treatment procedures like immunotherapy.

Nasal Treatment: How Immunotherapy Is Administered

Immunotherapy is the repeated administration of allergen vaccines to people who are experiencing severe allergy cases. This is done by injecting antigens into the patient’s skin. Its primary objective is to provide long-term relief and improve people’s quality of life by helping them get immune to a particular substance that they are allergic with. Physicians determine the antigen through skin testing and as well as by knowing the patient’s medical history.

The result of this treatment however does not come up immediately. This explains why the total treatment period for immunotherapy can last until 3-4 years. During the first treatment sessions, only a small dose of antigen is injected into the body. The amount of antigen is expected to increase in subsequent sessions. The doctor will assess how the patient’s body responds to the dosage and whether the body can tolerate the dosage. Patients need to see their doctor every 4-6 months to assess progress. At the very least, a patient will have to wait another 4-5 months or longer until relief of symptoms can be noticed.

Nasal Treatment: Management Of Adverse Effects

Although immunotherapy is considered the most effective treatment for severe allergies, it also has its risks. These include redness and swelling on the area of injection. This can be treated by taking antihistamine and by putting a cold compress on the portion of the skin where there is swelling. If the swelling seems to be severe, it is most recommended to report this to the doctor immediately.

Modifying the vaccine is one factor that experts are considering to avoid adverse side effects. In an article posted on the website of World Allergy Organization, vaccines for allergies can become more personalized by introducing recombinant allergens. However, there is no available literature yet concerning the trials of recombinant allergens for immunotherapy.

Comments are closed.